In the preclinical stage of hypertensive heart disease, higher circulating levels of TNF-R1 are associated with reduced exercise capacity, and this relationship may be mediated by the decline in LV diastolic function. The gene discussed is TNFRSF1A; the disease is hypertensive heart disease.